MedPath

CESAMET

CESAMET

Approved
DIN Number

02256193

Drug Class

Human

Market Date

Sep 16, 2004

Company
HC

bausch health, canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02256193
AIG Number0115009002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA II)
A
ATC Code
A04AD11 NABILONE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification56:22.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

NABILONEActive
Strength: 0.5 MG
Monograph: NABILONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.